FENOFIBRATE FOR REDUCING HYPOGLYCEMIA IN TYPE 1 DIABETES/LADA

摘要

The present invention relates to compositions comprising Fenofibrate for use in the treatment, prophylaxis and/or prevention of hypoglycaemia in type 1 diabetes or other related diseases in humans. This treatment, prophylaxis and/or prevention is particularly relevant for subjects that are genetically predisposed to these diseases. The daily dose ranges from 1-100 mg/kg bodyweight per day.